Healthcare Industry News: blood glucose monitoring
News Release - April 14, 2008
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With DiabetesNewly Designed Blood Glucose Meter Easier to Read and Offers Next-Generation Benefits that Can Help People Improve Their Diabetes Management
ABBOTT PARK, Ill., April 14 (HSMN NewsFeed) -- Abbott (NYSE: ABT ) today announced the availability of the FreeStyle Freedom® Lite blood glucose monitoring System (http://www.abbottdiabetescare.com/). Offering all of the benefits of Abbott's FreeStyle family of glucose monitoring systems, the newly designed FreeStyle Freedom Lite system provides accurate, reliable results that can help improve diabetes management (http://www.diabetescontrolforlife.com/), which can ultimately lead to better health.
By combining features such as no manual coding, which eliminates one step in the testing process; the world's smallest sample size requirement (0.3 microliter), meaning less pain; and one of the largest displays in an easy-to-read, easy-to-use meter, the FreeStyle Freedom Lite system gives people with diabetes a new option to help simplify their diabetes management routine.
"Diabetes is a unique health condition in that it requires a high degree of self-management," said Lorena Drago, MS, RD, CDN, CDE. "A glucose monitoring device that's easy to use and delivers quick, accurate results can be an invaluable asset in helping a person gain control of their diabetes today, and their long-term health tomorrow."
The FreeStyle Freedom Lite blood glucose monitoring System is available with an instructional video and product brochure in both English and Spanish.
About Abbott Diabetes Care
Abbott Diabetes Care, based in Alameda, Calif., is a leader in developing, manufacturing and marketing glucose monitoring systems designed to help people better manage their diabetes. Abbott Diabetes Care is committed to developing products that reduce the discomfort and inconvenience of glucose monitoring and introducing systems that are easier to use, require smaller samples and provide faster results.
Abbott Diabetes Care markets several leading-edge glucose monitoring systems and test strips in the United States for use in both home and hospital settings; leading brands include FreeStyle® Lite, FreeStyle Freedom® Lite, FreeStyle Freedom(TM), FreeStyle Flash® and Precision Xtra(TM), as well as its newest diabetes management tool, FreeStyle Navigator® Continuous Glucose Monitoring System. Additional information about Abbott Diabetes Care may be found at http://www.abbottdiabetescare.com.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 68,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsAbbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Abbott's Amplatzer(TM) Amulet(TM) Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management